Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …

Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…

Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward transmission. …

Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …

Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …

Visualizations of biomolecular structures empower us to gain insights into biological
functions, generate testable hypotheses, and communicate biological concepts. Typical …

Background Mortality rates in hospitalised patients with COVID-19 in the UK appeared to
decline during the first wave of the pandemic. We aimed to quantify potential drivers of this …

Background Dexamethasone was the first intervention proven to reduce mortality in patients
with COVID-19 being treated in hospital. We aimed to evaluate the adoption of …

Importance Multiple SARS-CoV-2 variants have emerged over the COVID-19 pandemic.
The implications for COVID-19 severity in children worldwide are unclear. Objective To …